8-143567280-C-T

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001100878.2(MROH6):​c.2119G>A​(p.Val707Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000409 in 1,222,560 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 0 hom. )

Consequence

MROH6
NM_001100878.2 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.141

Publications

0 publications found
Variant links:
Genes affected
MROH6 (HGNC:27814): (maestro heat like repeat family member 6)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0398463).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MROH6NM_001100878.2 linkc.2119G>A p.Val707Ile missense_variant Exon 14 of 14 ENST00000398882.8 NP_001094348.1 A6NGR9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MROH6ENST00000398882.8 linkc.2119G>A p.Val707Ile missense_variant Exon 14 of 14 5 NM_001100878.2 ENSP00000381857.3 A6NGR9

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
151808
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000314
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.000479
GnomAD4 exome
AF:
0.0000271
AC:
29
AN:
1070644
Hom.:
0
Cov.:
31
AF XY:
0.0000277
AC XY:
14
AN XY:
505480
show subpopulations
African (AFR)
AF:
0.000178
AC:
4
AN:
22494
American (AMR)
AF:
0.00
AC:
0
AN:
8106
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13866
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25888
South Asian (SAS)
AF:
0.00
AC:
0
AN:
19490
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
21012
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2854
European-Non Finnish (NFE)
AF:
0.0000263
AC:
24
AN:
914060
Other (OTH)
AF:
0.0000233
AC:
1
AN:
42874
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
151916
Hom.:
0
Cov.:
32
AF XY:
0.000148
AC XY:
11
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41490
American (AMR)
AF:
0.00
AC:
0
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10548
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
67852
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000117

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 26, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2119G>A (p.V707I) alteration is located in exon 14 (coding exon 14) of the MROH6 gene. This alteration results from a G to A substitution at nucleotide position 2119, causing the valine (V) at amino acid position 707 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
2.0
DANN
Benign
0.93
DEOGEN2
Benign
0.0017
T;.;.;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.041
N
LIST_S2
Benign
0.33
.;.;.;T
M_CAP
Benign
0.024
T
MetaRNN
Benign
0.040
T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.34
N;.;.;.
PhyloP100
-0.14
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.030
N;N;N;N
REVEL
Benign
0.040
Sift
Benign
0.39
T;T;T;T
Sift4G
Benign
0.28
T;T;T;T
Polyphen
0.019
B;.;.;.
Vest4
0.033
MutPred
0.087
Loss of methylation at R710 (P = 0.1009);.;.;.;
MVP
0.014
MPC
0.017
ClinPred
0.059
T
GERP RS
3.1
Varity_R
0.026
gMVP
0.022
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1389246625; hg19: chr8-144649450; API